Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
14 oktober, 15:15
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
PR Newswire
SAN DIEGO, Oct. 14, 2026
The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight
Included in the new platform, latest DRAGEN update expands access to Illumina's award-winning secondary analysis across supported cloud and standard computing environment
SAN DIEGO , Oct. 14, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today debuted the Illumina BioInsight Platform, the company's first unified software environment designed to help researchers turn complex genomic and multiomic data into meaningful biological evidence. By bringing together Illumina's analysis applications, purpose-built AI innovations, and curated data resources in one environment, the platform delivers flexibility and accessibility, while reducing the need to assemble and manage separate informatics tools as research questions evolve.
Ämnen i artikeln
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
14 oktober, 15:15
Illumina launches BioInsight Platform, its first unified software environment to help accelerate genomic and multiomic breakthroughs
PR Newswire
SAN DIEGO, Oct. 14, 2026
The new platform brings together advanced analysis, purpose-built AI, and curated biological data so researchers can move more quickly from complex genomic and multiomic data to actionable insight
Included in the new platform, latest DRAGEN update expands access to Illumina's award-winning secondary analysis across supported cloud and standard computing environment
SAN DIEGO , Oct. 14, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today debuted the Illumina BioInsight Platform, the company's first unified software environment designed to help researchers turn complex genomic and multiomic data into meaningful biological evidence. By bringing together Illumina's analysis applications, purpose-built AI innovations, and curated data resources in one environment, the platform delivers flexibility and accessibility, while reducing the need to assemble and manage separate informatics tools as research questions evolve.
Ämnen i artikeln
Aktier
Aktieanalyser
Aktier
Aktieanalyser
Marknadsöversikt
1 DAG %
Senast
1 mån
